CYP24A1

cytochrome P450 family 24 subfamily A member 1, the group of Cytochrome P450 family 24

Basic information

Region (hg38): 20:54153446-54173986

Previous symbols: [ "CYP24" ]

Links

ENSG00000019186NCBI:1591OMIM:126065HGNC:2602Uniprot:Q07973AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive infantile hypercalcemia (Supportive), mode of inheritance: AR
  • hypercalcemia, infantile, 1 (Strong), mode of inheritance: AR
  • hypercalcemia, infantile, 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hypercalcemia, infantile 1AREndocrine; RenalIndividuals may present early in life with typical hypercalcemic signs/symptoms (eg, failure to thrive,dehydration, and muscular hypotonia or lethargy), or may present later with nephrolithiasis and nephrocalcinosis, and dietary measures, including avoidance of certain vitamin supplements (eg, vitamin D-containing compounds) to avoid hypercalcemia can be beneficialEndocrine; Renal3490596; 21675912; 22047572; 23293122

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CYP24A1 gene.

  • not provided (13 variants)
  • Hypercalcemia, infantile, 1 (8 variants)
  • Ataxia-telangiectasia syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP24A1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
24
clinvar
5
clinvar
32
missense
3
clinvar
4
clinvar
86
clinvar
7
clinvar
4
clinvar
104
nonsense
5
clinvar
2
clinvar
7
start loss
0
frameshift
8
clinvar
3
clinvar
11
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
1
clinvar
7
splice region
3
4
1
8
non coding
32
clinvar
27
clinvar
50
clinvar
109
Total 18 13 123 58 59

Highest pathogenic variant AF is 0.000145

Variants in CYP24A1

This is a list of pathogenic ClinVar variants found in the CYP24A1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-54153484-T-C Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)896869
20-54153515-C-CAT Infantile hypercalcemia Benign (Jun 14, 2016)338789
20-54153637-G-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)896870
20-54153650-T-G Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)896871
20-54153677-G-C Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338790
20-54153681-G-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338791
20-54153758-G-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338792
20-54153785-A-G Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)896872
20-54153887-A-C Hypercalcemia, infantile, 1 Benign (Jan 13, 2018)338793
20-54153900-G-A Hypercalcemia, infantile, 1 Benign (Jan 13, 2018)338794
20-54153934-A-C Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)338795
20-54154024-C-T Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338796
20-54154056-C-T Hypercalcemia, infantile, 1 Benign (Jan 13, 2018)897370
20-54154057-G-C Hypercalcemia, infantile, 1 Benign (Jan 13, 2018)338797
20-54154058-GAC-G Infantile hypercalcemia Uncertain significance (Jun 14, 2016)338798
20-54154072-G-GAC Infantile hypercalcemia Uncertain significance (Jun 14, 2016)338799
20-54154223-T-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)897371
20-54154247-G-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)897372
20-54154254-T-C Infantile hypercalcemia Uncertain significance (Jun 14, 2016)338800
20-54154318-C-T Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338801
20-54154334-G-A Hypercalcemia, infantile, 1 Benign (Jan 13, 2018)338802
20-54154397-T-C Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)338803
20-54154455-A-G Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)338804
20-54154528-G-A Hypercalcemia, infantile, 1 Uncertain significance (Jan 12, 2018)338805
20-54154555-T-C Hypercalcemia, infantile, 1 Uncertain significance (Jan 13, 2018)898528

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CYP24A1protein_codingprotein_codingENST00000216862 1120525
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.20e-230.00014212562801201257480.000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.103322801.190.00001563345
Missense in Polyphen145121.481.19361411
Synonymous-0.9691231101.120.00000608973
Loss of Function-0.7293227.91.150.00000138329

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009260.000926
Ashkenazi Jewish0.000.00
East Asian0.001540.00152
Finnish0.0001390.000139
European (Non-Finnish)0.0004750.000466
Middle Eastern0.001540.00152
South Asian0.0002650.000261
Other0.0008260.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has a role in maintaining calcium homeostasis. Catalyzes the adrenodoxin-dependent 24-hydroxylation of calcidiol (25- hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin D(3)). The enzyme can perform up to 6 rounds of hydroxylation of calcitriol leading to calcitroic acid. It also shows 23- hydroxylating activity leading to 1-alpha,25-dihydroxyvitamin D(3)-26,23-lactone as end product. {ECO:0000269|PubMed:15574355}.;
Disease
DISEASE: Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]: A disorder characterized by abnormally high level of calcium in the blood, failure to thrive, vomiting, dehydration, and nephrocalcinosis. {ECO:0000269|PubMed:21675912}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Steroid biosynthesis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Vitamin D Metabolism;Vitamin D Receptor Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;PI3K-AKT-mTOR - VitD3 Signalling;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Vitamins;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Metabolism of steroids;Vitamin D3 (cholecalciferol) metabolism;Vitamin D (calciferol) metabolism;Steroid hormones (Consensus)

Recessive Scores

pRec
0.424

Intolerance Scores

loftool
0.973
rvis_EVS
0.02
rvis_percentile_EVS
55.76

Haploinsufficiency Scores

pHI
0.0881
hipred
N
hipred_score
0.419
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.219

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cyp24a1
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; renal/urinary system phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
osteoblast differentiation;vitamin metabolic process;response to vitamin D;vitamin D metabolic process;vitamin D catabolic process;oxidation-reduction process;vitamin D receptor signaling pathway
Cellular component
nucleus;nucleoplasm;mitochondrion;mitochondrial outer membrane;plasma membrane
Molecular function
iron ion binding;25-hydroxycholecalciferol-24-hydroxylase activity;oxidoreductase activity;heme binding;1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity